SPI1 and acute lymphoblastic leukemia: To test whether the leukemogenic activity could be modulated by SPI1 expression in human T-ALL cell lines, we injected placebo- or 5-AZ-treated CEM cells and monitored the T-ALL development induced by these cells in vivo.